# Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

> **NCT07007182** · PHASE2 · RECRUITING · sponsor: **Jinbo Yue** · enrollment: 54 (estimated)

## Conditions studied

- Gastric Adenocarcinoma
- Stomach Neoplasms

## Interventions

- **DRUG:** SOX regimen
- **DRUG:** CAPEOX regimen
- **DRUG:** PD-1 inhibitor
- **RADIATION:** Para-aortic lymph node radiotherapy (IMRT to station 16)
- **DRUG:** Capecitabine / S-1 (radiosensitizer during IMRT)

## Key facts

- **NCT ID:** NCT07007182
- **Lead sponsor:** Jinbo Yue
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2029-04-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007182, "Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07007182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*